scholarly journals Comparison of Linear Poly Ethylene Imine (LPEI) and Poly L-Lysine (PLL) in Fabrication of CHOK1 Cell-Loaded Multilayer Alginate Microcapsules

2020 ◽  
Vol 10 (2) ◽  
pp. 290-296
Author(s):  
Fariba Hajifathaliha ◽  
Arash Mahboubi ◽  
Elham Mohit ◽  
Noushin Bolourchian ◽  
Vahid Khalaj ◽  
...  

Purpose: Poly l-lysine (PLL) has been introduced as a strengthening covering layer for alginate microcapsules which are the most convenient way for cell encapsulation. Some disadvantages of PLL such as high price and low biocompatibility have prompted scientists to find better alternatives. Linear poly ethylene imine (LPEI), thanks to its highly similar structure to PLL, could be considered as a proper cost-effective alternative. In this study LPEI and PLL were compared as covering layers of cell-loaded alginate-LPEI-alginate (cALA) and alginate-PLL-alginate (cAPA) microcapsules. Methods: In addition to the physico-mechanical properties, the encapsulation efficiency, cell survival post encapsulation, cell viability, and cellular metabolic activity within the microcapsules were evaluated using trypan blue, live/dead cell staining, and MTT test, respectively. Results: Physico-mechanical evaluation of the microcapsules revealed that the cell microencapsulation process did not affect their shape, size, and mechanical stability. Although the encapsulation efficiency for cALA and cAPA was not different (P>0.05), cell survival post encapsulation was higher in cALA than in cAPA (P<0.05) which could be the reason for the higher cell viability and also cellular metabolic activity within these microcapsules in comparison to cAPA. Conclusion: Here, based on these results, ALA could be introduced as a preferable alternative to APA for cell encapsulation.

2014 ◽  
Vol 15 (4) ◽  
pp. 1124-1131 ◽  
Author(s):  
Christoph Englert ◽  
Lutz Tauhardt ◽  
Matthias Hartlieb ◽  
Kristian Kempe ◽  
Michael Gottschaldt ◽  
...  

2014 ◽  
Vol 113 ◽  
pp. 597-606 ◽  
Author(s):  
Sofia Ochrimenko ◽  
Antje Vollrath ◽  
Lutz Tauhardt ◽  
Kristian Kempe ◽  
Stephanie Schubert ◽  
...  

2011 ◽  
Vol 289 (8) ◽  
pp. 881-888 ◽  
Author(s):  
Andriy Shkilnyy ◽  
Stefanie Schöne ◽  
Claudia Rumplasch ◽  
Annett Uhlmann ◽  
Annett Hedderich ◽  
...  

2017 ◽  
Vol 8 (46) ◽  
pp. 7169-7179 ◽  
Author(s):  
Igor Perevyazko ◽  
Alexander S. Gubarev ◽  
Lutz Tauhardt ◽  
Anatoly Dobrodumov ◽  
Georges M. Pavlov ◽  
...  

In-depth characterization of pharmaceutically relevant polymers plays a pivotal role in many areas, including nanoscience, gene therapy, analytical and polymer chemistry etc.


2011 ◽  
Vol 115 (29) ◽  
pp. 9098-9105 ◽  
Author(s):  
Marco Finessi ◽  
Prashant Sinha ◽  
István Szilágyi ◽  
Ionel Popa ◽  
Plinio Maroni ◽  
...  

2010 ◽  
Vol 43 (2) ◽  
pp. 927-933 ◽  
Author(s):  
Hanneke M. L. Lambermont-Thijs ◽  
Friso S. van der Woerdt ◽  
Anja Baumgaertel ◽  
Lies Bonami ◽  
Filip E. Du Prez ◽  
...  

Circulation ◽  
2015 ◽  
Vol 132 (suppl_3) ◽  
Author(s):  
Lei Cai ◽  
Ruby Dewi ◽  
Zachary Strassberg ◽  
Luqia Hou ◽  
Abbygail Foster ◽  
...  

Introduction: Stem cell injection is a minimally invasive approach for treatment of cardiovascular diseases including peripheral arterial disease (PAD), which affects over 8 million patients in the US. However, poor cell survival and low cell retention at injection site are critical bottlenecks to the efficacy of stem cell therapy. We developed a shear-thinning and self-healing hydrogel system with controllable rigidity for stem cell encapsulation so as to enhance transplant cell viability. Hypothesis: The injectable hydrogel system will prolong cell survival under ischemic conditions and maintain cellular phenotype, in comparison to cell injection in saline. Methods: We developed a hydrogel comprised of two complementary engineered proteins that self-assemble upon simple mixing. The hydrogel network incorporates a polyethylene glycol physical crosslinker that modulates hydrogel stiffness and degradation. Bioluminescently-labeled human induced pluripotent stem cell-derived endothelial cells (iPSC-ECs) were encapsulated within the hydrogel with controllable stiffness (G'~10-800 Pa) under conditions of hypoxia (1% O2). The cells within hydrogel were then subjected to an in vitro model of injection and assayed for cell survival, proliferation, and endothelial phenotype for up to 14 days. To verify these results in an experimental model of PAD, 10^6 cells were injected in saline or in 400 Pa hydrogel into the ischemic limb in SCID mice. Results: Acutely after injection, the survival of iPSC-ECs in saline was 65%, whereas survival of iPSC-ECs in hydrogels with stiffnesses of 10, 100, 400, and 800 Pa was 94%. Bioluminescence imaging of cell viability in hypoxia for 14 days demonstrated the highest proliferation in the hydrogel with 400 Pa stiffness. In the 400 Pa hydrogel, iPSC-ECs maintained elongated morphology with robust expression of endothelial phenotypic marker, CD31. In the ischemic hindlimb, iPSC-EC retention was markedly increased with hydrogel encapsulation, compared to saline delivery. Conclusions: These findings demonstrate that stem cell encapsulation within this protein hydrogel improves cell viability, which may have therapeutic benefit for treatment of PAD and broadly to myocardial ischemia.


2011 ◽  
Vol 360 (2) ◽  
pp. 580-585 ◽  
Author(s):  
István Szilágyi ◽  
Dana Rosická ◽  
José Hierrezuelo ◽  
Michal Borkovec

Sign in / Sign up

Export Citation Format

Share Document